Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414019 | SCV000492183 | uncertain significance | not provided | 2021-02-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously reported as a germline pathogenic or benign variant to our knowledge |
Labcorp Genetics |
RCV000414019 | SCV003245391 | likely benign | not provided | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002521429 | SCV003556235 | uncertain significance | Inborn genetic diseases | 2021-07-06 | criteria provided, single submitter | clinical testing | The c.5404T>C (p.Y1802H) alteration is located in exon 28 (coding exon 28) of the C2CD3 gene. This alteration results from a T to C substitution at nucleotide position 5404, causing the tyrosine (Y) at amino acid position 1802 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |